The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: A double-blind clinical trial - 09/09/11
Doi : 10.1016/S0190-9622(98)70337-8
Joseph L. Jorizzo, MDa, Mark Lebwohl, MDb, Raymond E. Tobey, MDc
Winston-Salem, North Carolina, New York, New York and Radnor, Pennsylvania
From the Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem ,a the Department of Dermatology, Mount Sinai Medical School, New York ,b and Radnor Pharmaceutical Consultancy, Radnor .c
Plan
 | Supported by Dermik Laboratories, Inc., 500 Arcola Rd, Collegeville, PA 19426. |
| Dr Tobey formerly was Vice President of Research and Development, Dermik Laboratories, Inc. |
 | Co-investigators for this study included Drs Drore Eisen, Cincinnati, Ohio; Coleman Jacobson, Dallas, Tex; Sewon Kang, Ann Arbor, Mich; H. Irving Katz, Fridley, Minn; Roland S. Medansky, Chicago, Ill; Eugene W. Monroe, Milwaukee, Wis; David M. Pariser, Norfolk, Va; Ronald C. Savin, New Haven, Conn; Jonathan S. Weiss, Snellville, Ga; Dow Stough, Hot Springs, Ark; and Richard G. Asarch, Englewood, Colo. |
| Reprint requests: Sharon F. Levy, MD, Dermik Laboratories, Inc., PO Box 1200, 500 Arcola Rd, Collegeville, PA 19426. |
| ♢ | J Am Acad Dermatol 1998;39:502-4. |
| ♢♢ | 0190-9622/98/$5.00 + 0 16/54/91005 |
© 1998
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 39 - N° 3
P. 502-504 - septembre 1998 Retour au numéro
Article précédent
- Bullous lichen sclerosus et atrophicus
- Dafna Hallel-Halevy, Marcelo H. Grunwald, Joseph Yerushalmi, Sima Halevy
- A familial dermatofibrosarcoma protuberans
- Timothy L. Gardner, Dirk M. Elston, Paul J. Wotowic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?